Recibido: 12-12-2018 Aceptado: 17-01-2019 Resumen: La diabetes mellitus tipo 1 (DM1), es una enfermedad crnica caracterizada por la deficiencia de insulina debido a la prdida de clulas pancreticas, las alteraciones hormonales en la DM 1 no se limitan a la deficiencia de insulina
According to a guideline by the American Pain Society, tailored exercise and cognitive-behavioral therapy are among the top treatments for managing symptoms (Goldenberg et al., 2004)
Educate patients taking GLP-1 receptor agonists who have risk factors for developing NAION about the importance of presenting to their eyecare provider immediately should they experience any painless monocular vision loss
The titration schedule requires 8-12 weeks to reach working dose, and most users maintain their target dose for an additional 4-12 weeks during the active cutting phase
Aram thoroughly evaluates each person and gives an accurate cost estimate for their treatment plan to promote weight loss
If you have type 2 diabetes, obstructive sleep apnea, or MASH, your GLP-1 is covered under standard Medicare Part D through the indication-specific pathway not the Bridge